CureBay, an Indian healthtech company specializing in rural healthcare delivery and AI-assisted diagnostics, has raised approximately ₹100 crore ($10.6 million) in a pre-Series C round to scale operations and expand its technology capabilities.
- Raised ₹100 crore ($10.6M) in pre-Series C round
- Plans to expand rural clinics from 250 to 800
- Advancing AI-based diagnostics and preventive care programs
What happened
CureBay secured ₹100 crore in funding consisting of over ₹69 crore in equity led by IvyCap Ventures and approximately ₹30 crore in debt financing from Trifecta Capital, Alteria Capital, and VentureSoul Partners. This capital influx aims to support CureBay's geographic expansion, scale its rural healthcare delivery network, and enhance its AI and technology infrastructure for screening and patient care.
The startup, which currently operates in Odisha, Chhattisgarh, Jharkhand, and Bihar, intends to enter Telangana and Andhra Pradesh markets. It plans to increase its rural clinic footprint from 250 locations to 800 within the next two to three years. The funding round also follows prior investments exceeding $34 million from known investors like Bertelsmann India Investments and British International Investment.
Why it matters
CureBay serves underserved rural populations by connecting patients with doctors, hospitals, diagnostic labs, and pharmacies through a hybrid model of physical clinics, community health workers, and a digital platform. Its focus on AI-assisted screening addresses critical healthcare gaps in remote areas, leveraging trained AI models for skin conditions, dental health, and haemoglobin monitoring.
The startup’s preventive care initiative, Kavach, offers subscription-based consultations and support for medicines, diagnostics, and hospital costs, aligning with broader public health goals to reduce disease burden through early detection and continuous care. CureBay's ability to generate nearly ₹170 crore in annual recurring revenue and break even on operating EBITDA in FY26 underscores growing market trust and business sustainability potential.
What to watch next
Key metrics to monitor include CureBay’s expansion progress in Telangana and Andhra Pradesh, the growth of its rural clinic network towards 800 sites, and the development and rollout of new AI screening products beyond the current focus areas. Upcoming updates on FY27 revenue growth targets and operating EBITDA trajectory will be critical indicators of scalability and profitability.
Additionally, how CureBay manages the balance between rapid geographic expansion costs and achieving company-level profitability will be crucial. The startup plans to reach profitability once it stabilizes its operations and stops expanding, spotlighting operating EBITDA as its main financial health metric to track in the near term.